ABSTRACT
This special issue consists of 17 papers dealing with issues animal health (captive and wild primates), environmental health (rain forests and mountain areas), and human health (the role of religion in One Health, lessons from the Hanuman langur (Semnopithecus entellus) and other human-non-human primate interactions,and Covid-19).
ABSTRACT
In this article the author discusses how electrophoresis can aid in the diagnosis and treatment of inflammatory and infectious diseases in animals such as feline infectious peritonitis, Leishmania infantum and neoplasms.
ABSTRACT
This article is a 2021 update on the WHO report on the impact of COVID-19 on neglected tropical diseases (NTD) and the response appropriated by the WHO. In January 2021, and after almost 2 years of wide-ranging consultations, WHO launched the new NTD roadmap for 2021-2030 that provides a framework and actions to drive progress towards a world free of NTDs, contributing during this decade to the attainment of the United Nations Sustainable Development Goals through: fundamental shifts that put countries, communities and people at the centre of the agenda;supportive cross-sectoral actions, such as health, education, nutrition, water, sanitation, and hygiene and;sustaining and accelerating progress towards the 2030 goals. Furthermore, the roadmap provides opportunities to evaluate, assess, and adjust programmatic actions, as and when needed, over the next decade by setting clear targets and milestones. Another distinct feature of this roadmap is to drive greater ownership by national and local governments, including communities. The overarching 2030 global targets are to: (1) reduce by 90% the number of people requiring interventions against NTDs;(2) have at least 100 countries having eliminated at least one NTD;(3) eradicate 2 diseases (dracunculiasis and yaws) and;(4) reduce by 75% the DALYs related to NTDs. The roadmap will enable future measuring of progress towards eradication, elimination and control of the 20 NTDs by tracking disease-specific targets. Additionally, the roadmap includes 10 cross-cutting targets relevant to progress in the areas of integration, multisectoral coordination, universal health coverage, and country ownership. Examples include a reduction by more than 75% in the number of deaths from vector-borne NTDs such as dengue and leishmaniasis;100% access to basic water supply, sanitation, and hygiene in areas endemic for NTDs;75% integrated treatment coverage index for preventive chemotherapy;90% countries including NTDs in their package of essential services, and 90% countries collecting and reporting NTD data disaggregated by gender.
ABSTRACT
In September 2021 (from 00:00, 1 September to 24: 00, 30 September), a total of 500 929 cases of notifiable communicable diseases, including 2 172 deaths, were reported in China (except Hong Kong, Macao Special Administrative Regions and Taiwan Province, the same below). In communicable diseases in class A, no case and no death were reported. In communicable diseases in class B, no cases and no deaths of severe acute respiratory syndrome, poliomyelitis, human infection with highly pathogenic avian influenza virus, diphtheria and human infection with avian influenza A(H7N9) virus were reported. For the remaining 22 communicable diseases in class B, 272 332 cases were reported, a decrease of 0.9% compared with last month (274 917 cases) and a decrease of 5% compared with the same period in 2020 (287 923 cases). The first 5 diseases in terms of reported case number were viral hepatitis, pulmonary tuberculosis, syphilis, gonorrhea and brucellosis, accounting for 94% of the total reported cases in class B. A total of 2 172 deaths were reported, an increase of 5% (95 deaths) compared with last month (2 077 deaths) and a decrease of 5% compared with the same period in 2020 (2 291 deaths). According to the website of the National Health Commission of China, a total of 1 264 confirmed COVID-19 cases were reported, without death, by 31 provinces (municipalities, autonomous regions) and Xinjiang Production and Construction Corps from 00:00, 1 September to 24: 00, 30 September, 2021. In class C communicable diseases, a total of 228 597 cases were reported, an increase of 10% compared with last month (207 153 cases) and a decrease of 7% compared with the same period in 2020 (247 112 cases). The first 3 diseases in terms of reported case number were other infectious diarrhea, hand foot and mouth disease (HFMD) and influenza, accounting for 93% of the total reported cases in class C. Compared with last month, except filariasis, visceral leishmaniasis, leprosy and other infectious diarrhea which decreased by 1 case, 11 cases (39%), 12 cases (33%) and 12 747 cases (12%) respectively, the reported cases of all other diseases increased, the diseases with obvious case increases were HFMD (15 352 cases, 22%), influenza (14 160 cases, 66%) and mumps (4 253 cases, 51%). Compared with the same period in 2020, the diseases with reported case increases were influenza (17 269 cases, 95%), visceral leishmaniasis (4 cases, 31%), rubella (19 cases, 27%) and typhus fever (32 cases, 18%), filariasis had no incidences in both years, and the diseases with obvious reported case decreases were HFMD (26 506 cases, 23%). other infectious diarrhea (5 628 cases, 6%) and mumps (523 cases, 4%). No death caused by class C communicable diseases was reported, same to the last month and a decrease of 3 deaths compared with the same period in 2020 (3 deaths).
ABSTRACT
Objective: To explore the pharmacological mechanism of Xuanbai Qingfei Jiedu Decoction in the treatment of coronavirus disease 2019 (COVID-19) on account of network pharmacology.